Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Tumor Protein P53 Inducible Protein 13 (TP53I13) Peptide

TP53I13 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN985389
$160.46
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 11 to 16 Business Days

Quick Overview for Tumor Protein P53 Inducible Protein 13 (TP53I13) Peptide (ABIN985389)

Target

TP53I13 (Tumor Protein P53 Inducible Protein 13 (TP53I13))

Origin

Human

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Characteristics

    This is a synthetic peptide designed for use in combination with anti-TP53I13 antibody (Catalog #: ARP51702_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    TP53I13 (Tumor Protein P53 Inducible Protein 13 (TP53I13))

    Background

    TP53I13 may act as a tumor suppressor. It inhibits tumor cell growth, when overexpressed. TP53I13 was up-regulated by genotoxic stresses of adriamycin and/or ultraviolet beam irradiation in a p53-dependent manner

    Alias Symbols: DSCP1

    Protein Size: 393

    Molecular Weight

    42 kDa

    Gene ID

    90313

    NCBI Accession

    NM_138349, NP_612358

    UniProt

    Q8NBR0
You are here:
Chat with us!